Sorafenib and Regorafenib in HBV- or HCV-positive hepatocellular carcinoma patients: Analysis of RESORCE and SHARP trials

Research output: Contribution to journalLetter

Original languageEnglish
Pages (from-to)943-944
Number of pages2
JournalDigestive and Liver Disease
Volume49
Issue number8
DOIs
Publication statusPublished - Aug 1 2017

ASJC Scopus subject areas

  • Hepatology
  • Gastroenterology

Cite this